Abstract: Oxidative stress, characterized by an imbalance between increased exposure to free radicals and antioxidant defenses, is a prominent feature of many acute and chronic diseases and even the normal aging process. However, definitive evidence for this association has often been lacking due to recognized shortcomings with methods previously available to assess oxidant stress status in vivo in humans. Several in vitro markers of oxidative stress are available, but most are of limited value in vivo because thay lack sensitivity and/or specificity or require invasive methods. Isoprostanes (IsoPs) are prostaglandin (PG)-like compounds that are produced in vivo independently of cyclooxygenase enzymes, primarily by free radical-induced peroxidation of arachidonic acid. F 2 -IsoPs are a group of 64 compounds isomeric in structure to cyclooxygenase-derived PGF 2 . Other products of the IsoP pathway are also formed in vivo by rearrangement of labile PGH 2 -like IsoP intermediates including E 2 -and D 2 -IsoPs, cyclopentenone-A 2 -and J 2 -IsoPs, and highly reactive acyclicketoaldehydes (isoketals).
INTRODUCTION
Oxidative stress is characterized by an imbalance between increased exposure to reactive oxygen species (ROS) and antioxidant defenses, comprised of both small molecular weight antioxidants, such as glutathione, and antioxidant enzymes, such as superoxide dismutase. ROS can be generated endogenously from a number of sources (for example, mitochondria and oxidative burst during phagocyte activation) or derived from endogenous sources such as environmental toxins and cigarette smoke. Free radicals cause direct damage to critical biomolecules including DNA, lipids, and proteins. Oxidative stress is now recognized to be a prominent feature of many acute and chronic diseases including cancer, cardiovascular disease, neurodegenerative disease, lung disease and even the normal aging process. However, definitive evidence for this association has often been lacking due to recognized shortcomings with methods previously available to assess oxidant stress status in vivo in humans [1] .
Several in vitro markers of oxidative stress are available, but most are of limited value in vivo because they lack sensitivity and/or specificity or require invasive methods [2] . Iso-*Address correspondence to this author at the Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Largo F. Vito, 1, 00168 Rome, Italy; Tel: 0039-06-30156092; Fax: 0039-06-30156292; Email: pmontuschi@rm.unicatt.it prostanes (IsoPs) are prostaglandin (PG)-like compounds that are produced in vivo independently of cyclooxygenase (COX) enzymes, primarily by free radical-induced peroxidation of arachidonic acid (C20:4 6) [3] .
The formation of PG-like compounds during autooxidation of polyunsaturated fatty acids was first reported in the mid 70s [4] , but IsoPs were not discovered to be formed in vivo in humans until 1990 [3] . F 2 -IsoPs are a group of 64 compounds isomeric in structure to COX-derived PGF 2 ( Fig. 1) . Other products of the IsoP pathway are also formed in vivo by rearrangement of labile PGH 2 -like IsoP intermediates. These include E 2 -and D 2 -IsoPs [5] , cyclopentenone-A 2 -and J 2 -IsoPs [6] , and highly reactive acyclic-ketoaldehydes (isoketals) (Fig. 2) [7] . Oxidation of docosahexaenoic acid (C22:6 3), an abundant unsaturated fatty acid in the central nervous system, results in the formation of IsoP-like compounds, termed neuroprostanes [8] .
The discovery of IsoPs has important implications for medicine [5] : first, it has now been established that measurement of F 2 -IsoPs is the most reliable approach to assess oxidative stress status in vivo, providing an important tool to explore the role of oxidative stress in the pathogenesis of human disease. In addition, products of the IsoP pathway have been found to exert potent biological effects and therefore may be pathophysiological mediators of disease. The number of publications related to IsoPs is increasing at an exponential rate [9] . We summarize the biological impor-tance of lipid peroxidation and oxidative stress and how they are currently measured. We describe the IsoP pathway and focus on the advantages of measuring F 2 -IsoPs as biomarkers of lipid peroxidation, the clinical utility of measuring F 2 -IsoPs for monitoring disease and response to therapy, their potential role as mediators of oxidative stress, and the therapeutic implications of this knowledge.
OXIDATIVE STRESS AND LIPID PEROXIDATION
Lipids are a major target of free radical attack, which induces lipid peroxidation. Lipid peroxidation is a selfpropagating phenomenon which is terminated by antioxidants (See below; R• = free radical species, L = lipid, A = antioxidant). Free radical-induced peroxidation of membrane lipids can also be very damaging because it leads to alterations in the biophysical properties of the membrane, such as the degree of fluidity, and can also lead to inactivation of membrane-bound receptors or enzymes, which in turn may impair normal cellular function. Moreover, generation of highly reactive secondary aldehyde products of lipid peroxidation, e.g. isoketals from the IsoP pathway and 4-hydroxynonenal [10] , may contribute and amplify cellular damage due to their ability to covalently modify critical biomolecules. Therefore, measurement of products of lipid peroxidation has been one of the most commonly used approaches to assess oxidative stress injury.
THE ISOPROSTANE PATHWAY
F 2 -IsoPs were the first class of IsoPs discovered [11] . IsoPs may be formed by either of two routes of peroxidation [11] [12] [13] , an endoperoxide mechanism or a dioxetane/endoperoxide mechanism. However, the extent to which the dioxetane/endoperoxide mechanism is responsible for the formation of the IsoPs in vivo is unknown [14] . Biosynthetic steps of IsoPs include: (1) formation of three arachydonyl radicals; (2) formation of four peroxyl radical isomers with subsequent endocyclization; (3) formation of four bicycloendoperoxide regioisomers which are then reduced to F 2 -IsoPs ( Fig. 1) [14] . Oxygen centered radicals including hydroxyl, perhydroxyl and peroxyl radicals, superoxide anion, -hydroxy-ethyl radical, and radicals derived from acetalde- 
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[H] hyde and cytochrome P450 enzymes can abstract a hydrogen atom from arachidonic acid and propagate a chain reaction [13] . In the endoperoxide mechanism, following precursor arachidonic acid peroxidation, three arachidonyl radicals and four different peroxyl radical isomers are produced through abstraction of an allylic hydrogen atom and subsequent insertion of oxygen [14] . Peroxyl radical isomers undergo endocyclization and addition of another molecule of oxygen to form four PGH 2 -like bicyclic endoperoxide intermediate regioisomers (Fig. 1) . These are reduced to four F-ring regioisomers, each consisting of eight racemic diastereoisomers. Therefore, 64 different F 2 -IsoP diastereoisomers can be formed [11] . The dioxetane/endoperoxide mechanism for IsoP formation leads to the production of the same regioisomers [15] . In the endoperoxide mechanism, the first oxygen molecule is incorporated into the endoperoxide ring to form the two hydroxyl groups on the PGF ring, whereas, in the dioxetane/endoperoxide mechanism, it is the second oxygen molecule that is incorporated into the PGF ring [15] . The Eicosanoid Nomenclature Committee has approved a nomenclature system for the IsoPs, in which the different regioisomer classes are designated by the carbon number of the side chain where the hydroxyl is located, with the carboxyl carbon designated as C-1 ( Fig. 1 ) [16] . In this review, we will use this nomenclature system. Based on this nomenclature system, the four classes of regioisomers are denoted as either 5-, 12-, 8-, or 15 series. The absolute configuration of the ring hydroxyls is only oriented cis, although they can either be oriented down ( ), the default configuration, or up ( ) [14] . In this case, the compound is designated "ent" [14] . The default side chain configuration of IsoPs relative to the prostane ring is cis, whereas if the side chains are trans the compound is designated "epi" [14] . The notation of either "t" or "c" placed as a subscript indicates whether the side chains are oriented cis or trans with respect to the cyclopentane ring hydroxyls [14] . An alternative nomenclature system classifiyng IsoPs classes or types based on -carbon as being the starting reference has been proposed [13] . This system considers differences in chain length and position of double bonds of various IsoPs [13] . Roman numerals III-VI refer to the four types of IsoP regioisomers derived from arachidonic acid [13] . Letters D, E, F, G, and H indicate the type of cyclopentane ring [13] .
Using mass spectrometry techniques, it has been demonstrated that each of the four classes of regioisomers are formed in vivo in experimental animals exposed to carbon tetrachloride (CCl 4 ) to induce acute oxidative stress [17] . Among 64 diastereoisomers, over 45 F 2 -IsoPs could be separated, suggesting random production of each regioisomeric subtype in this in vivo model [17] . The most abundant isomers identified were 5-and 15-series isomers constituting 33% and 25% of the total products, respectively [17] . 8-and 12-series isomers were of less abundance because, in contrast to intermediates involved in the formation of 5-and 15-series compounds, intermediates involved in the formation of these regioisomers undergo an additional cyclization step to form a novel group of molecules which are termed dioxolane-IsoPs [14, 18] .
It has been noted that structural differences, although small, between IsoPs and COX derived PGs, account for marked differences in the biological actions of IsoPs compared to PGs [14] . As F-ring compounds derive from the reduction of endoperoxide intermediates, the hydroxyls on the prostane ring are only oriented cis, either , or , [11, 14] . Moreover, unlike enzymatically derived PGs, nonenzymatic production of the IsoPs favors compounds in which the side chains are predominantly oriented cis in relation to the isoprostane ring [14] . F 2 -IsoPs are initially formed on esterified phospholipids [19] . The mechanism(s) responsible for the release of free IsoPs from membrane phospholipids is largely unknown. However, this process is likely mediated by phospholipase(s) A 2 [19] . Increased formation of free F 2 -IsoPs is induced by activators of phospholipase A 2 such as calcium ionophore A23187 and hydrogen peroxide as shown by in vitro experiments in the isolated human umbelical vein [20] . Intracellular and plasma platelet-activating factor acetylhydrolases have a central role in the hydrolysis of F 2 -IsoPs esterified on phospholipids in vivo [21] .
IsoP endoperoxides may also undergo rearrangement in vivo to form an E-ring or D-ring, and thromboxane-ring compounds [5] (Fig. 2) . Levels of D 2 /E 2 -IsoPs esterified in different rat tissues are about one-third to one-fourth the levels of F 2 -IsoPs [14, 22] . In contrast to F 2 -IsoPs, D 2 /E 2 -IsoPs cannot be detected in the plasma of humans or rats under normal circumstances, although they can be detected in the circulation of rats that have been administered CCl 4 to induce severe lipid peroxidation [5] . This might be due to differences in the rate of metabolic clearance of D 2 /E 2 -and F 2 -IsoPs [5] . E 2 -and D 2 -IsoPs also undergo dehydration in vivo to form cyclopentenone A 2 -and J 2 -IsoPs [6] (Fig. 2) which are formed in large amounts in vivo unlike cyclopentenone PGs, for which little evidence exists that they are endogenously produced [23] . Highly reactive -ketoaldehydes (isoketals or isolevuglandins) may also be formed in vivo as products of IsoP endoperoxide rearrangement [7] (Fig. 2) . E 2 -and D 2 -isoketals, the major classes of isoketals formed, have ketone moieties at either C-9 or C-11, similar to COX derived PGE 2 and PGD 2 . Isoketals, which can be generated by myeloperoxidase in vivo [24] , readily adduct to lysine residues on proteins and cause protein-protein as well as DNA-protein crosslinking [25, 26] . For this reason, isoketals cannot be detected in free form in protein-containing biological systems [7] . Isoketal-protein adducts generated upon oxidation of low-density lipoproteins (LDL) may contribute to atherogenesis since such adducts cause recognition and endocytosis of the modified LDL by macrophage cells [25] .
The metabolic fate of IsoPs is mostly unknown except for 15-F 2t -IsoP (also known as 8-iso-PGF 2 ). Unlike metabolism of prostaglandins, a single metabolite predominates in the profile of derivatives produced from metabolism of 15-F 2t -IsoP [2] . 2,3-dinor-5,6-dihydro-15-F 2t -IsoP is the major urinary metabolite of 15-F 2t -IsoP in humans and rats [27, 28] (Fig. 3) . 2,3-dinor-15-F 2t -IsoP, another -oxidation product, has been identified as a major product of 15-F 2t -IsoP metabolism in urine in humans [29] . After intravenous administration to rabbits, 15-F 2t -IsoP is rapidly metabolized to 15-keto-15-F 2t -IsoP and -oxidised products [30] . -tetranor-15-keto-13,14-dihydro-15-F 2t -IsoP is a major urinary metabolite in rabbits [30] and 2,3,4,5-tetranor-15-F 2t -IsoP has been identified as a major product of rat hepatocyte metabolism [29] .
The major urinary metabolite of 15-A 2t -IsoP, one of the most abundant A 2 -IsoPs produced in vivo, has been recently identified in rats exposed to oxidant stress [31] . The metabolite was identified as the N-acetyl cysteine (or the mercapturic acid) sulfoxide conjugate in which the carbonyl at C-9 was reduced to an alcohol [31] . The identification of this metabolite combined with the finding that these metabolites are produced in in vivo settings of oxidant stress makes it possible to use this method to quantify the in vivo production of cyclopentenone prostanoids [31] . Because the metabolism of IsoP can differ between different animal species, studies are currently ongoing to determine the major urinary metabolite of 15-A 2t -IsoP in primates [31] . Docosahexaenoic acid (C22:6 3) is the most abundant unsaturated fatty acid in the central nervous system. Oxidation of this 22-carbon fatty acid may result in the formation of IsoP-like compounds, termed neuroprostanes, which may be a unique biomarkers of oxidative neuronal injury [8] . As with IsoPs, neuroprostane bicyclic endoperoxide intermediates are reduced to F-rings (F 4 -neuroprostanes) or undergo rearrangement to E-and D-ring compounds (E 4 /D 4 -neuroprostanes) [32, 33] (Fig. 4) . F 4 -, D 4 -, E 4 -, A 4 -, and J 4 -neuroprostanes and neuroketals have all been shown to be produced in vivo [33] . A number of different F 4 -neuroprostane regioisomers are formed from the peroxidation of docosahexaenoic acid ( because the precursors that lead to regioisomers other than those 4-and 20-series can be further oxidized to form novel dioxolane-IsoP-like compounds, analogous to those generated from arachidonate [34] . Considering the regioselectivity in the formation of neuroprostanes, studies of the biological activities of neuroprostanes focused on the more abundantly generated compounds to determine their role in modulating the pathophysiological consequences of docosahexaenoic acid oxidation and oxidant stress are warranted [34] . E 4 /D 4 -neuroprostanes can undergo dehydration resulting in the formation of cyclopentenone neuroprostanes, termed A 4 /J 4 -neuroprostanes [35] (Fig. 4) . Endoperoxides may also undergo rearrangement to form highly reactive isoketal-like compounds, termed neuroketals [36] (Fig. 4) .
Limited to 15-F 2t -IsoP, an enzymatic synthesis via COX-1 and/or COX-2 has been reported in vitro [37] [38] [39] and in vivo [40] . However, non-selective COX inhibition does not affect urinary excretion of 15-F 2t -IsoP in healthy subjects [41] or in patients with pathophysiological conditions associated with platelet activation and increased F 2 -IsoP production [42, 43] . Moreover, COX activation contributes undetectably to 15-F 2t -IsoP formation in healthy subjects who were given endotoxin to induce inflammation [44] . Current evidence indicates that the COX pathway is a trivial contributor to overall 15-F 2t -IsoP generation in vivo [5, 45] . 5-F 2t -IsoP exhibits no capacity for enzymatic synthesis [46] .
A new pathway of lipid peroxidation that forms compounds with substituted tetrahydrofuran ring (isofurans) has recently been discovered [33, 47, 48] (Fig. 6) . Oxygen concentration differentially modulates the formation of IsoPs and isofurans. As oxygen concentrations increase, the formation of isofurans is favored whereas the formation of IsoPs becomes disfavored [33] .
Oxidation of eicosapentaenoic acid (20:5 3) (EPA), the most abundant polyunsaturated fatty acid in fish oil, results in the formation of F 3 -IsoPs in vivo in mice which are virtually undetectable at baseline, but are markedly increased after supplementations of animals with EPA [49] .
MEASURING OXIDATIVE STRESS: ADVANTAGES OF THE ISOPROSTANES
Despite the importance of measuring lipid peroxidation to explore the potential role of oxidative stress in the pathogenesis of human diseases, no previously existing assay of lipid peroxidation was considered "ideal". Assays that had been previously developed had several shortcomings related to (1) the specificity of the assay itself for the product of lipid peroxidation being measured, (2) the product being measured was not a specific product of lipid peroxidation, (3) the lack of sufficient sensitivity to detect levels of the product being measured in normal subjects, thus allowing the definition of a normal range, (4) levels of the product being measured being influenced by external factors, such as the lipid content of the diet, or (5) the assay being too invasive for human investigation [50] . The most widely used test for oxidative stress is the measurement of malondialdehyde (MDA), a product of lipid peroxidation, by the thiobarbituric acid-reacting substances (TBARS) assay [10] . However, the use of this assay to assess oxidative stress status is problematic because MDA is not a specific product of lipid peroxidation and the TBARS assay is not specific for MDA [50] . Another method of assessing lipid peroxidation in vivo is the measurement of exhaled volatile alkanes, such as ethane and pentane [51] . However, the accuracy of exhaled pentane as a marker of endogenous lipid peroxidation has been questioned [52] ; these hydrocarbon gases are minor end-products of lipid peroxidation and their concentrations are influenced by the breakdown rate of peroxides [50] . A variety of methods have also been used to measure lipid hydroperoxides.
However, marked inconsistencies have been found with levels detected, e.g. in human plasma, rising questions regarding accuracy of assay methodology [53] . Moreover, lipid hydroperoxyde concentrations in the circulation are undetectable, even under conditions of severe oxidative stress, using a highly accurate and sensitive gas chromatography/mass spectrometry (GC/MS) assay [2] , making this approach to assess oxidative stress status in humans of little or no value.
F 2 -IsoPs are currently considered the best available biomarkers of oxidative stress status and lipid peroxidation in vivo [2, 54] , whereas other products of the IsoP pathway such as D 2 -and E 2 -IsoPs are less suitable as they are less stable [2] . Although IsoPs are not a major product of lipid peroxidation, currently available methodology is able to readily detect their steady-state levels in vivo [5] . F 2 -IsoPs are ini- tially formed in situ esterified in phospholipids and then released in free form by phospholipase action [19] . F 2 -IsoPs are detectable in their esterified form in all normal biological tissues and in free form in all normal biological fluids, indicating "physiological" levels of oxidative stress [2, 5, 45] . Approaches to assess endogenous production of F 2 -IsoPs in humans include measurement of free unmetabolized F 2 -IsoPs in biological fluids such as plasma and urine, measurement of esterified F 2 -IsoPs in biopsy specimens and plasma lipoproteins, and measurement of the major urinary metabolite of the F 2 -IsoP 15-F 2t -IsoP, 2,3-dinor-5,6-dihydro-15-F 2t -IsoP, which may provide an accurate assessment of total endogenous F 2 -IsoP production [2] .
Measurement of F 2 -IsoP has several advantages over other quantitative markers of oxidative stress [2] . substantially in animal models of oxidant injury, (f) are unaffected by lipid content in the diet [55] [56] [57] [58] , and (g) might provide a sensitive biochemical basis in dose-finding studies with antioxidants [2] . IsoPs are frequently measured in urine, because it is non-invasive, IsoPs are not formed artifactually by auto-oxidation in urine, and they are very stable in urine [58] . There is no significant daily variability of urinary IsoP concentrations in healthy subjects [37, 55, 59] ; and day-to-day variability in healthy and disease states is relatively limited [42, 46, 60, 61] , although one study reported significant variability [62] . F 2 -IsoPs have also been detected in exhaled breath condensate (EBC), a completely non-invasive method to collect secretions from the airways which is suitable for repeated measures of inflammation and oxidative stress in patients with lung disease, including young children and adults with severe disease [63, 64] . Measurement of F 2 -IsoPs esterified in plasma lipoproteins may provide a useful approach to assess oxidation of LDL in vivo [38, 65] , a central feature of atherosclerosis. Measurement of F 2 -IsoPs in tissues and/or biological fluids provides a valuable new approach to the quantification of oxidative stress as well as a biochemical basis for assessing therapeutic intervention. In fact, one of the key issues in performing an interventional trial with an antioxidant is to establish whether the treatment decreases oxidative stress in the study subjects and at what dose(s) [50] . Moreover, measurement of the level of lipid peroxidation as reflected by F 2 -IsoP concentrations in biological fluids may help to identify those patients most likely to benefit from antioxidant treatment.
One shortcoming associated with measurement of F 2 -IsoPs has been recognized. Because of the mechanism by which F 2 -IsoPs are generated, their formation is impaired at elevated oxygen tensions, so that, measurement of F 2 -IsoPs is an insensitive marker of lipid peroxidation in settings of elevated oxygen tension, such as hyperoxia-induced lung injury. However, the recent discovery of isofurans, products of lipid peroxidation with a substituted tetrahydrofuran ring, whose formation is favored as oxygen tension increases, overcomes this limitation with measurement of F 2 -IsoPs [47, 48] . Future studies may indicate that combined measurement of both F 2 -IsoPs and isofurans affords the best assessment of oxidative stress under all circumstances than either measurement alone.
ANALYTICAL METHODS
MS is the reference analytical method for IsoP measurements in biological fluids and tissues [2, 66, 67] . Novel LC/MS methods have been applied to the analysis of F 2 -IsoPs for separating and identifying F 2 -IsoP regioisomers and diastereoisomers and assessing their relative formation in vitro and in vivo [67] . A deuterated analog of 15-F 2t -IsoP has been synthesised and its metabolism has been characterised [68] . A relatively high throughput LC/MS assay to measure dinor, dihydro metabolites of F 2 -IsoPs in urine has been recently devloped [69] . As MS methods are timeconsuming and expensive, immunoassays for the measurement of IsoPs have been developed and are commercially available. A radioimmunoassay has been quantitatively validated by GC/MS analysis of 15-F 2t -IsoP and cross-reactivity with other F 2 -IsoP isomers is very low [41] . However, the immunoassays have not been tested for cross-reactivity with the F 2 -IsoP metabolites, which might be formed in vivo [45] .
Moreover, while some immunoassays have been shown to correlate rather well with GC/MS measurements [41] , other have not [70] .
ISOPROSTANES AS BIOMARKERS OF OXIDATIVE STRESS IN HUMAN DISEASES
The measurement of IsoPs in biological fluids and/or tissue specimens has important clinical implications. Measurement of F 2 -IsoPs has implicated a role of free radicals and oxidant injury in a wide variety of human diseases, including cardiovascular, pulmonary, neurological, renal, and liver diseases ( Table 1) [2, 5, 45] . Although the association between increased oxidative stress and disease does not necessarily imply a causative link, the fact that the increase in F 2 -IsoP levels is an early event in asthma [71, 72] , hepatic cirrosis [73] , scleroderma [74] , and Alzheimer's disease [75, 76] suggests a causative role for oxidative stress at least in these diseases. Chronic healthy smokers have higher free and esterified F 2 -IsoP plasma concentrations and urinary excretion of F 2 -IsoP metabolites compared to healthy non-smokers, indicating pro-oxidant effects of smoking in vivo [42, 77] . This conclusion is further supported by the fact that IsoP levels return to baseline values after two weeks smoking cessation [77] . Since LDL oxidation may lead to atherosclerosis, these findings may provide a causative link between smoking and the development of atherosclerosis [5, 77] . In addition, approximately 2-fold increase in urinary excretion of 15-F 2t -IsoP was associated with an approximately 30-fold increased risk in coronary heart disease exceeding that of Creactive protein [78] . Therefore, 15-F 2t -IsoP has been proposed as a new independent and cumulative risk biomarker for coronary heart disease together with diabetes mellitus, arterial hypertension, hypercholesterolemia, cigarette smoking, and elevated C-reactive protein [78] . However, the casecontrol study design used in this study does not allow to assess the value of 15-F 2t -IsoP for predicting future coronary events for which cohort studies are required [78] . Measurement of IsoPs may also have prognostic value in those diseases in which a role for oxidative stress has been implicated.
The issue of whether lipid peroxidation is part of the pathogenesis of Alzheimer's disease or a consequence of neurodegeneration is still uncertain. However, current evidence suggests that oxidative stress is an early event which may play an important role in the pathogenesis of Alzheimer's disease [75, 76, 79, 80] . F 2 -IsoP concentrations in cerebrospinal fluid are elevated early in the course of dementia [81] , and correlate with disease severity [82, 83] and progression. Measurement of CSF F 2 -IsoPs can increase the accuracy of laboratory-based classification of geriatric dementias, and have been used to assess objectively the response to anti-oxidant interventions in Alzheimer's disease [80] . F 2 -IsoP and F 4 -neuroprostane brain levels are elevated in patients with mild cognitive impairement indicating that lipid peroxidation might have a role in the pathogenesis of Alzheimer's disease [84] . F 2 -IsoPs are levated in urine in young patients with Down's syndrome which is associated with precocious Alzheimer's disease-like pathology and dementia [85] .
Pericardial F 2 -IsoP concentrations increase with the functional severity of heart failure and are associated with ven-tricular dilatation suggesting a possible role for in vivo oxidative stress on ventricular remodeling and the progression to heart failure [86] .
In patients with lung diseases, 15-F 2t -IsoP concentrations in EBC reflect the degree of airway inflammation [71, 87, 88] with the highest levels reported in patients with acute lung injury/adult respiratory distress symdrome [89] who have the most severe disease. Likewise, urinary IsoP concentrations correlate with disease severity in scleroderma [90, 91] .
BIOLOGICAL EFFECTS
IsoPs are not only biomarkers of oxidative stress, but also have numerous biological effects, suggesting that they may also function as pathophysiological mediators of oxidant injury. Most of the current knowledge on the biological actions of F 2 -IsoPs is limited to 15-F 2t -IsoP, which is potent vasoconstrictor. In the rat, F 2 -IsoPs reduce glomerular filtration rate and renal blood flow by 40-45% in the low nanomolar range [3, 92] . In experimental animals, 15-F 2t -IsoP also has constrictor effects in other vascular beds including pulmonary artery [3] , coronary arteries [93] , cerebral arterioles [94] , retinal vessels [95] , and portal vein [96] . F 2 -IsoPs potently induce retinal vascular endothelial cell death in newborn rats and piglets [97] . Interestingly, it has been found that 2,3-dinor-5,6-dihydro-15-F 2t -IsoP, the major urinary metabolite of 15-F 2t -IsoP, is also a potent constrictor of retinal and brain microvessels, comparable to that observed with 15-F 2t -IsoP [98] .
15-F 2t -IsoP contracts human and guinea-pig airway smooth muscle in vitro [99] , causes airflow obstruction and plasma exudation in guinea-pigs in vivo [100] , and bronchoconstriction and vasoconstriction in isolated perfused rat lung [101] . 15-F 2t -IsoP has been shown to produce airway hyperresponsiveness (AHR) in mouse lung [102] . The increase in F 2 -IsoP formation induced by allergen challenge in whole lung in mice is causally linked to increased AHR, an important feature of asthma [103] . However, due to the interspecies variability in the response to F 2 -IsoPs [104] , the relevance of these findings for patients with asthma is uncertain.
The E-ring IsoP, 15-E 2t -IsoP, is also a potent renal vasoconstrictor [5] more efficacious, although equipotent, than 15-F 2t -IsoP in human pulmonary artery, while the two IsoPs are equally potent and effective in the human and canine pulmonary veins [105] . Like 15-F 2t -IsoP, 15-E 2t -IsoP has been found to have excitatory effects on every vascular • Creutzfeld-Jacob's disease [159] • Crohn's disease [165] • Osteoporosis [166] • Chronic fatigue syndrome [167] • Systemic lupus erythematosus [168] smooth muscle in which it has been tested [104] . Apart from the bronchodilator effect on canine airway smooth muscle, 15-E 2t -IsoP is, in general, a bronchoconstrictor as it causes contraction of airway smooth muscle of the rat [101] , guinea-pig [99] , human [99, 105] . The fact that 15-F 2t -IsoP and 15-E 2t -IsoP have similar effects on vascular and airway smooth muscle is in striking contrast with the opposing biological effects of COX-derived PGF 2 and PGE 2 in most systems which has been attributed to differences in ring structure [14] . Unlike 15-F 2t -IsoP and 15-E 2t -IsoP, structurally related 8-iso-PGF 2 and 8-iso-PGF 3 lack any spasmogenic activity on airway smooth muscle [104] , whereas 8-iso-PGF 1 and 8-iso-PGF 2 are ineffective as vasoconstrictors [106] . Taken together, this evidence suggests that biological responses to IsoPs are compound, species, and tissue specific. Therefore, extrapolating the biological effects of the other IsoPs from 15-F 2t -IsoP should be avoided [104] and each IsoP should be studied separately as it becomes available in a synthetic form.
IsoPs have important in vitro activities that could be relevant to the pathophysiology of atherosclerosis [107] . F 2 -IsoPs promote platelet activation [107] and induce mitogenesis in vascular smooth muscle cells [92] . Moreover, F 2 -IsoP formation is increased during LDL oxidation in vitro [65] and they are also major contributors to the proadhesive effect induced by minimally oxidatively modified LDL on neutrophils [108] . IsoPs stimulate proliferative responses in fibroblasts [109] , cause hypertrophy of rat neonate ventricular myocytes [110] , and can also alter endothelial cell biology as indicated by proliferative effects and increased endothelin-1 expression in bovine aortic endothelial cells [111] . A recent study has shown that 15-F 2t -IsoP directly promotes atherogenesis in two different mouse models (ie, apoprotein E [apoE]-and LDL receptor-deficient mice) by activating the thromboxane (Tx) receptor (TP) supporting a pathophysiological role for F 2 -IsoPs in atherosclerosis [112] . Sodium channel dysfunction evoked by lipid peroxidation with formation of isoketals is a possible mechanism for ischemiarelated conduction abnormalities and arrhythmias [113] . At present it is not known whether the concentrations of IsoPs reached locally in vivo are sufficient to exert biological effects, because no specific inhibitor of their biological actions exists (vide infra). However, their overproduction may contribute to the increased platelet activation in patients with diabetes [114] , bronchoconstriction in patients with asthma [99] , decreased renal blood flow in the hepatorenal syndrome [5, 115] and rhabdomyolysis-induced renal failure [116, 117] , fetal/newborn hypoxic-ischemic encephalopathies [94] , and in some complications of cardiac reperfusion injury such as myocardial stunning [107] . Isoketals, highly reactive products of the IsoP pathway, and isoketals adducted proteins inhibit proteasome activity and, if produced in excess, may have relevance to the pathogenesis of neurodegenerative diseases and other diseases involving oxidative stress that are known to be associated with impaired proteasome function [118] . Cyclopentenone IsoPs induce neuronal apoptosis at submicromolar concentrations under conditions of oxidative stress indicating that these compounds may contribute to neurodegeneration caused by ROS [119, 120] .
In addition to their direct effects, IsoPs can also modulate the relase of neurotransmitters such as norepinephrine from mammalian iris ciliary bodies [121, 122] and D-aspartate from bovine isolated retinae [123, 124] .
Interestingly, protective effects of IsoPs and related compounds have been recently reported. Cyclopentenone IsoPs inhibit the inflammatory response in murine macrophages [125] . In particular, 15-A 2 -and 15-J 2 -IsoPs potently inhibit lipopolysaccharide-stimulated I B degradation and subsequent NF-B nuclear translocation and transcriptional activity, expression of inducible nitric-oxide synthase and COX-2, and nitrite and PG production [125] . 15-J 2 -IsoP potently activates peroxisome proliferator-activated receptor (PPAR ) nuclear receptors, whereas 15-A 2 -IsoP does not [125] . 15-A 2 -IsoP inhibit the NF-B pathway at least partially via a redox-dependent mechanism indicating that cyclopentenone IsoPs may serve as negative feedback regulators of inflammation and have important implications for defining the role of oxidative stress in the inflammatory response [125] . 15-F 2t -IsoP suppresses the attachment of monocytes to human dermal microvascular endothelial cells, an early event in the inflammatory response [126] . Whether this potential antiinflammatory effect of 15-F 2t -IsoP in the microvasculature also occurs in the human in vivo and its relevance for the inflammatory response process and its modulation requires further research.
MECHANISM OF ACTION
Products of the IsoP pathway exert their biological effects by both receptor-mediated interactions, e.g. vasoconstriction in the case of F 2 -IsoPs and E 2 -IsoPs [5] , and through their inherent chemical reactivity, e.g. adduct formation, in the case of cyclopentenone-IsoPs and isoketals. Cyclopentenone IsoPs contain highly reactive , -unsaturated carbonyl moieties on the prostane ring analogous to COX-derived PGA 2 and PGJ 2 that readily react with thiol-containing biomolecules to produce a range of biological effects [6, 127] . Isoketals rapidly adduct to lysine residues on proteins and induce cross-links at rates that exceed other aldehyde products of lipid peroxidation [7] . In vitro studies have shown that isoketals form oxidized pyrrole adducts (lactams and hydroxylactams) with the -amino group of lysine [7, 128] (Fig. 7) . Moreover, E 2 -isoketals, which are formed in a canine model of myocardial infarction, potentiate inactivation of cardiac sodium channels in human cultured atrial (HL-1) myocytes [113] .
The nature of the receptor(s) involved in the IsoP actions is not yet certain. Mechanism(s) of action of F 2 -IsoPs include interaction with the TP receptor and/or a unique IsoP receptor. While the vasoconstricting and vascular proatherogenic effects of 15-F 2t -IsoP can be abolished by TP receptor antagonists, suggesting that it acts as an incidental ligand at TP receptors [5, 112, 129] it acts primarily as an antagonist of Tx receptor agonist-induced platelet aggregation [130] . The differential agonist/antagonist activity of 15-F 2t -IsoP in the vessels versus the platelets could be explained by different receptor isoforms in these tissues or the presence of a unique IsoP receptor [14] . The TP receptor is a G-protein coupled transmembrane receptor encoded by a single gene but with two different splice variants, TP-a (platelet and placenta) and TP-b (endothelial) [131] . The two receptor isomers associate with two different G-proteins which may couple to both common and unique signalling pathways leading to increase in intracellular calcium, phosphoinositide turnover, and activation of protein kinase C [14] . Experiments in transgenic mice indicate that the cardiovascular effects of 15-F 2t -IsoP are mediated through the interaction with the TP receptor in vivo [129, 132] . Overexpression of TP-b receptor in the vessels of transgenic mice was associated with increased pressor response to infused 15-F 2t -IsoP compared with wild type mice [129] and this effect was abolished by TP receptor antagonists [129] . By contrast, mice lacking the TP gene did not have the effects of 15-F 2t -IsoP on blood pressure and platelet function [129] . Evidence for the existence of a unique IsoP receptor come from functional, binding, and transfection studies. 15-F 2t -IsoP is more potent at inducing a functional response and increase in inositol 1,4,5-triphosphate on vascular smooth muscle cells than TP receptor agonists and these effects are only partly abrogated by TP receptor antagonists, whereas 15-F 2t -IsoP is weaker than TP receptor agonists in displacing TP ligand binding [14, 133] . COS-7 transfected cells which have only the TP receptor are completely insensitive to 15-F 2t -IsoP [132] . The presence of low and high affinity binding sites for 15-F 2t -IsoP in smooth muscle cells further supports the existence of a unique IsoP receptor as 15-F 2t -IsoP activates mitogen-activated protein kinase at doses lower than those required to stimulate the TP receptor (reviewed in [132] ). Interestingly, in piglet retinal and brain vasculature, 15-F 2t -IsoP has been shown to cause vasoconstriction by inducing Tx formation in the endothelium [94, 95] . Part of the airway responses to 15-F 2t -IsoP may be due to TxA 2 formation [100] and this IsoP induces PGF 2 formation which might enhance its pro-inflammatory and contractile effects [134] . Other IsoPs including 15-F 2c -IsoP (12-iso-PGF 2 ) and 15-E 2t -IsoP activate FP [109, 110] and ET 3 receptors [135] , respectively. However, F 2 -IsoPs also activate other prostanoid receptors (FP and ET 3 ) [109, 110, 135] . Molecular cloning of the putative isoprostane receptor would clarify the mechanism(s) of action of these compounds. Ion channels can also be involved in the IsoP mechanism of action. It has recently be shown that 15-F 2t -IsoP activates calcium-dependent potassium current via cyclic AMP signalling pathway in murine renal artery [136] . 
THERAPEUTIC IMPLICATIONS
Measurement of F 2 -IsoPs provides investigators with a unique tool to assess the role of free radicals in the pathogenesis of human disease with a degree of reliability that previously had not been possible. As detailed above, the occurrence of oxidative stress has now been established utilizing measurements of F 2 -IsoPs in a wide variety of diseases, the number of which continues to increase. An important question that follows is whether oxidative stress plays a fundamental role in the pathogenesis of these diseases. The definitive answer to that question can only be forthcoming by determining whether the lowering the level of oxidative stress by treatment with effective antioxidants affects the manifestations and progression of the disease. There are demonstrations where adiministration of antioxidants has in fact ameliorated disease processes in animal models of human disease which are associated with overproduction of IsoPs, but presently this has been less clear in humans. For example, animal models of atherosclerosis, such as ApoE deficient mice, have demonstrated that antioxidant therapy reduces the progression or induces the regreassion of atherosclerosis [137] . Increased F 2 -IsoP concentrations in urine, plasma and vascular tissue are associated with atherogenesis in these mice [137] and vitamin E administration reduces F 2 -IsoP production, aortic atherosclerotic areas, and F 2 -IsoP levels in the arterial wall without reducing plasma cholesterol levels [137] . These findings suggest that oxidative stress is important in the evolution of atherogenesis in ApoE deficient mice. By contrast, the results of large prospective, controlled, clinical trials assessing the efficacy of vitamin E supplementation in the prevention of cardiovascular disease are controversial [138] . Vitamin E supplementation was found to be highly efficacious in two trials (CHAOS and SPACE), but six other trials (ATBC, GISSI, PPP, SECURE, HOPE, and VEAPS) failed to show any benefit [139] . The reasons for this discrepancy are unclear, but factors such as selection of patients with varying levels of oxidative stress and dose of vitamin E may influence outcomes. In regards to the latter, it should be noted that these trials tested with widely varying doses of vitamin E ranging from 55 to 800 I.U./day. It is important to point out that the clinical pharmacology of vitamin E has not been defined, so that it is not yet known what doses of vitamin E are necessary to suppress oxidative stress in humans. Moreover, none of these studies incorporated measures of oxidative stress, such as measurement of F 2 -IsoPs, to determine the level of oxidative stress and the ability of vitamin E to effectively lower the level of oxidative stress in the study subjects. This makes it very difficult to interpret the results of these studies. In small single human studies involving subjects with conditions associated with elevated levels of F 2 -IsoPs, some have found that vitamin E supplementation reduces the production of F 2 -IsoPs whereas others have not [43, 114, 115, 140, 141] . In a cohort of 100 men enrolled in the "Antioxidant Supplementation in Atherosclerosis Prevention" trial, treatment with 200 mg of d--tocopherol once a day for one year reduced plasma F 2 -IsoP concentrations by about 20%, whereas vitamin C (500 mg once a day for one year) was not effective and its combination with vitamin E decreased the effect of vitamin E alone [142] . In healthy subjects, vitamin E has no effect on urinary F 2 -IsoP concentrations at doses up to 2,000 I.U./day for up to eight weeks [143] . Moreover, a high dose of vitamin C (2,500 mg/day) had no effect on lowering F 2 -IsoP levels in normal subjects [144] but was found to be very effective in suppressing IsoP formation in smokers [77] . This latter finding may be explained by the fact that plasma concentrations of vitamin C, but not other antioxidants, are markedly reduced in smokers [77] . Ascorbic acid supplementation (500 mg, twice daily for 2 weeks) reduces -and -tocopheroxyl radicals to nonoxidized forms, thereby decreasing vitamin E disappearance in humans [145] . Smaller doses of vitamin C (500 mg/day) have also been shown to be effective in suppressing IsoP production in smokers but only in subjects with high body mass index and supplementation with the same dose of vitamin C in combination with additional antioxidants (vitamin E and lipoic acid) was ineffective [146] . In a single dose supplementation clinical study with vitamin C and vitamin E, F 2 -IsoP formation was reduced compared to no supplementation [147] . What these findings suggest is that oxidative stress is a complex phenomenon which may be influenced by a number of covariates and that appropriate selection of an antioxidant(s) and dose to effectively suppress oxidative stress in specific situations is less than predictable. On the other hand, it also suggests that measurements of F 2 -IsoPs may provide a uniquely valuable approach to elucidate these complexities and establish effective antioxidant dose regimens that can then be formally tested in individuals with a variety of disease states to determine if amelioration of oxidative stress mitigates manifestations of disease.
CONCLUSIONS
The initial report of the discovery of F 2 -IsoPs was primarily a biochemical curiosity demonstrating that PG-like compounds can be formed in vivo independent of the COXs. However, over the last several years, the importance of that discovery began to emerge. At that time, it had been well appreciated that methods that had been developed to assess oxidative stress status in vivo were unreliable, which impeded investigators from being able to unequivocally establish the occurrence of oxidative stress in human disease. It has since become clear that measurement of F 2 -IsoPs provides a valuable and reliable approach to assess oxidative stress status in vivo. Measurement of F 2 -IsoPs has firmly established the occurrence of oxidative stress in a wide variety of disease states, often for the first time. Moreover, F 2 -IsoPs and other products of the IsoP pathway have been shown to exert potent biological actions both via receptordependent and independent mechanisms and may therefore participate as mediators of oxidant injury. While firmly establishing the occurrence of oxidative stress in a human disease is an important first step, this alone does not establish whether oxidative stress plays a fundamental role in the pathogenesis of that disease. This can only be forthcoming by demonstrating that amelioration of the oxidative stress by treatment with antioxidants mitigates manifestations of the disease. To accomplish that requires an in depth understanding of the clinical pharmacology of antioxidant agents, which currently is lacking. Unfortunately, many large clinical trials of antioxidants have been conducted that may have used either an appropriate antioxidant for that specific disease or an inappropriate dose. Advances in our understanding of the clinical pharmacology of antioxidants, however, should be obtainable utilizing measurements of F 2 -IsoPs.
This would greatly inform our interpretation of the results of these clinical trials and inform future trials regarding appropriate antioxidant treatment regimens to test. The discovery of IsoPs advances greatly our ability to explore the role of oxidative stress in the pathogenesis of disease, therefore impacting in an important way on clinical medicine.
